Nabulsi Azmi 4
4 · Phathom Pharmaceuticals, Inc. · Filed Dec 20, 2024
Insider Transaction Report
Form 4
Nabulsi Azmi
Chief Operating Officer
Transactions
- Sale
Common Stock
2024-12-19$8.00/sh−1,118$8,944→ 239,303 total
Holdings
- 3,578.93(indirect: By 401(k))
Common Stock
- 785,700(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.